AP INFOSENSE
Technological Ingenuity and Relentless Pursuit of Excellence

As photonic technology and biotechnology converge, new opportunities for process optimization are emerging for different sectors. AP INFOSENSE leverages the potential of these technologies to open new avenues for businesses.

The Hong Kong-based firm is dedicated to two pivotal streams of innovation—metrology sensors for industrial applications and advanced biotechnology solutions in regenerative medicine and chronic disease prevention.

“We create and refine biomedical sensors and laser tracker modules to ensure precision and quality. Our in-house expertise and dedicated R&D team pioneer advanced sensing technologies ready for IoT platforms in the areas of 3D vision, precision engineering, sensors, robotics, medical devices, and advanced fabrication,” says Dr. Emily Chan, vice president of AP INFOSENSE.

Dr. Chan's leadership embodies the company's commitment to innovation and precision with a background spanning in photonic R&D design, and impressive 17-year tenure in high-tech manufacturing, including optical module manufacturing. Her specialization in electronic engineering and optical fiber, coupled with proficiency in photonic waveguide design, positions her at the forefront of technological advancement.

With Chan at the helm, AP INFOSENSE is pushing the capabilities of photonic technology.

Its interferometric modules are capable of advanced data extraction and yielding unparalleled sub-micron level precision. Instead of depending on traditional, contact-based methods involving meticulous line-by-line measurements using probe needles, manufacturers now get control over dimensional accuracy.

AP INFOSENSE harnesses photonic design and sophisticated algorithms to venture into biotechnology measurements. An exemplary feat is the non-invasive 3D profiling of live stem cells using white light sensors. This novel approach shuns the use of lasers and dyes, minimizing phototoxicity, effectively differentiating cell characteristics, and allowing cells to thrive postmeasurement— an innovation poised to transform regenerative medicine. This provides a much-needed solution for stem cell researchers to monitor various cell forms and cultures, aiding in detecting anomalies early and optimizing experimental conditions.

The company’s journey is deeply intertwined with Hong Kong's Innovation and Technology Commission, marking its commitment to impactful research and development. It has inherited a rich legacy of technological expertise with roots in the AP Group—a company that has established successful, high-tech businesses through the commercialization of innovative industrial technologies with leading-edge competency in sensor, photonic, precision engineering, computer control, artificial intelligence, software, and robotics.

The impact of AP INFOSENSE's advancements in the biomedical realm is profound.

Venturing into manufacturing, particularly for hardware like FPGA chips, has become increasingly difficult posing a significant challenge for photonic chip designers pursuing high-speed precision measurement. AP INFOSENSE's approach involves seeking fresh perspectives and innovative solutions, while remaining open to collaborating with diverse talents, both young and experienced, to tackle these challenges head-on.

As the field increasingly relies on rapid measurement, to usher in high-precision metrology for biotechnology and meet the rising requirements, AP INFOSENSE leverages the integration of cutting-edge engineering with logical problem-solving to reshape industries and elevate scientific exploration.